| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401. | J Clin Oncol | 2006 | 2.89 |
| 2 | Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer. | Clin Cancer Res | 2006 | 1.38 |